EDITAS MEDICINE, INC. Lease, Cost
EDITAS MEDICINE, INC. (EDIT) reported Lease, Cost of $1.73 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Operating Expenses
us-gaap:LeaseCost · last filed 2019-11-12
- EDITAS MEDICINE, INC. lease, cost for the quarter ending 2019-09-30 was $1.73M.
- EDITAS MEDICINE, INC. lease, cost for the quarter ending 2019-06-30 was $1.68M.
- EDITAS MEDICINE, INC. lease, cost for the quarter ending 2019-03-31 was $1.69M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month |
|---|---|---|---|
| 2019-09-30 | $1.73M 10-Q · filed 2019-11-12 | $3.41M derived: sum of 2 quarters · filed 2019-11-12 | $5.10M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.68M 10-Q · filed 2019-08-07 | $3.37M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.69M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |